Author: Olivia Dimmer
-
Weight Loss Drug Shows Benefits for Heart Failure
Semaglutide, sold under brand names Ozempic and Wegovy, can help reduce heart failure symptoms and reduce heart failure hospitalizations in patients with obesity, according to a pair of studies published in The Lancet and The New England Journal of Medicine.
-
B-Cells May Play Role in Lung Transplant Rejection
B-cells infiltrating the lungs may be responsible for one of the most common complications in lung transplantation that can lead to rejection, according to a study published in the Journal of Clinical Investigation.
-
Drug Shows Promise for Starving Out Cancer Cells
Starving out tumor cells may be a promising therapy for treatment-resistant lung cancer, according to a study published in Science Advances.
-
Understanding Cellular Transcription Responses to Oxygen Deprivation
A multiprotein complex is essential for regulating cellular transcription response to oxygen deprivation, a key feature of cancer, according to a Northwestern Medicine study published in the Proceedings of the National Academy of Sciences.
-
Northwestern and CERN Step into Collaborative Leadership Role, Fostering Innovation in Open Science
Kristi Holmes, PhD, associate dean for knowledge management and strategy and director of Galter Health Sciences Library will co-lead the initiative focused on enhancing open-source scientific data.
-
Setting International Standards for Diagnosing Pediatric Sepsis
A large international team led by a Northwestern Medicine investigator has established new standardized diagnostic criteria for pediatric sepsis, according to two related studies published in JAMA.
-
Trailblazing Biochemist Delivers Kimberly Prize Lecture
Influential biochemist Craig M. Crews, PhD, who pioneered the pharmaceutical field of targeted protein degradation, delivered the second Kimberly Prize in Biochemistry and Molecular Genetics Lecture to a full auditorium of Feinberg faculty, staff, fellows and students.
-
‘Polypills’ Can Help Patients Reduce Heart Disease Risk
Combining multiple heart disease drugs into a single “polypill” can lower bad cholesterol and blood pressure, boost medication adherence, and reduce the risk of cardiovascular disease and death, according to a meta-analysis of recent clinical trials published in Nature Medicine.
-
Developing Tools to Explore DNA Methylation
A Northwestern Medicine study has detailed the development of a machine learning model to predict DNA methylation status in cell-free DNA by its fragmentation patterns, according to findings published in Nature Communications.
-
Probing Deeper to Understand Protein Expression in Neurons
Northwestern Medicine investigators have developed a method to measure protein expression in an individual neuron type, according to a study published in Molecular Psychiatry.
